Hangzhou Fuluo Biological Technology Co.,Ltd.

  High quality, competitive price, fast delivery

         WhatsApp:+8615372437208  

         E-mail:nancypeng@ycphar.com

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsAnti Estrogen Steroids

CAS 82640-04-8 Raloxifene Hydrochloride Testosterone Anabolic Steroid

Good quality Testosterone Steroids for sales
Good quality Testosterone Steroids for sales
The Anavar suspended way better than it usual doed for me.Those could be postitive things.I'm Just making sure.

—— Jason

Your product help me put on nice clean gains no water retention or unwanted fat

—— Leo

Hey Nancy, Sorry for not replying,Ive been in the hospital for some time.I had some testers use both yohimbine and cialis which they said worked exce

—— Gordon

Thanks for understanding.i had to tell your competitors to go away.I only buy from you.in loyal.you've all been very good to me.I'll need 200g of test

—— Jordan

thanks for your continued great service. Jordy

—— Jordy

Hi Nancy! Just did HPLC test on RAD 140 now: Very happy here

—— Francois

I'm Online Chat Now

CAS 82640-04-8 Raloxifene Hydrochloride Testosterone Anabolic Steroid

China CAS 82640-04-8 Raloxifene Hydrochloride Testosterone Anabolic Steroid supplier
CAS 82640-04-8 Raloxifene Hydrochloride Testosterone Anabolic Steroid supplier CAS 82640-04-8 Raloxifene Hydrochloride Testosterone Anabolic Steroid supplier

Large Image :  CAS 82640-04-8 Raloxifene Hydrochloride Testosterone Anabolic Steroid

Product Details:

Place of Origin: wuhan,hubei
Brand Name: saichuang
Certification: iso9001
Model Number: 82640-04-8

Payment & Shipping Terms:

Minimum Order Quantity: 10gram
Price: US 3-4/gram
Packaging Details: Discreet package for delivery guarantee
Delivery Time: 3-5 working days
Payment Terms: T/T, Western Union, MoneyGram,Bitcoin
Supply Ability: 1ton/month
Contact Now
Detailed Product Description
Product Name: Raloxifene HCl CAS Register Number: 82640-04-8
Molecular Formula: C28H28ClNO4S Molecular Weight: 510.05
Appearance: White Crystalline Powder Grade: Pharmaceutical Grade

Description

 

Raloxifene (marketed as Evista) is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.

This drug is different from hormones (including estrogens and progestins). It works by acting like estrogen (as a selective estrogen receptor modulator or SERM) in some parts of the body. Raloxifene helps to preserve bone mass, but it does not affect the breast and uterus like estrogen or relieve symptoms of menopause such as hot flashes.

Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women. It is also used for reduction of risk and treatment of invasive breast cancer, and it also reduces breast density.For either osteoporosis treatment or prevention, supplemental calcium and/or vitamin D should be added to the diet if daily intake is inadequate.

Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause. Maintaining strong bones by slowing bone loss helps to reduce the risk of fractures.

Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive) in women after menopause.

 

Applications

 

May prevent or treat corticosteroid-induced bone loss .American College of Rheumatology states that raloxifene can be offered to selected postmenopausal corticosteroid-treated women who refuse hormone replacement therapy or other antiresorptive agents (e.g., bisphosphonates, calcitonin) or in whom such therapies are contraindicated.

 

Reduction in the incidence of invasive breast cancer in postmenopausal women with osteoporosis.

 

Reduction in the incidence of invasive breast cancer in postmenopausal women at high risk for developing the disease. Effect comparable to that of tamoxifen in reducing the risk of invasive breast cancer (STAR trial).No effect on the risk of lobular carcinoma in situ or ductal carcinoma in situ (STAR trial).Effect on breast cancer incidence in women with BRCA1 or BRCA2 genetic mutations not established.

 

Not indicated for the treatment of breast cancer or to reduce the risk of recurrence of breast cancer.1 Not indicated for reduction in the risk of noninvasive breast cancer.

 

Side Effect


Raloxifene may infrequently cause serious blood clots to form in the legs, lungs, or eyes. Other reactions experienced include leg swelling/pain, trouble breathing, chest pain, vision changes. Raloxifene is a teratogenic drug, i.e., can cause developmental abnormalities such as birth defects.

 

More Product

 

 

Anavar CAS: 53-39-4
Anadrol CAS: 434-07-1
Winstrol CAS: 10418-03-8
Dianabol CAS: 72-63-9
Superdrol CAS: 3381-88-2
Tamoxifen Citrate (Nolvadex) CAS: 54965-24-1
Clomiphene Citrate (Clomid) CAS: 50-41-9
Toremifene Citrate (Fareston) CAS: 89778-27-8
Letrozole CAS: 112809-51-5
Aromasin CAS: 107868-30-4
Proviron CAS: 1424-00-6
Arimidex CAS: 120511-73-1
Formestane CAS: 566-48-3
Cabergoline (Caber) CAS: 81409-90-7
Finasteride CAS: 98319-26-7
Dutasteride CAS: 164656-23-9

CAS 82640-04-8 Raloxifene Hydrochloride Testosterone Anabolic Steroid

 

Contact Details
Hangzhou Fuluo Biological Technology Co.,Ltd.

Contact Person: Jay

Tel: +8615355470358

Send your inquiry directly to us (0 / 3000)